Markets

BioDelivery Sciences International (BDSI) Jumps: Stock Up 14.1% - Tale of the Tape

BioDelivery Sciences International, Inc. ( BDSI ) was a big mover last session, as its shares rose over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend trend for the company, as the stock is now up nearly 33% in the past one-month timeframe.

In the last 7 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's rally can turn into more strength down the road.

BioDelivery Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. ( GILD ), ANI Pharmaceuticals, Inc. ( ANIP ) and Illumina Inc. ( ILMN ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

BIODELIVERY SCI (BDSI): Free Stock Analysis Report

GILEAD SCIENCES (GILD): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GILD ANIP BDSI ILMN

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More